Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries

Publication date

2022-11-14

Authors

PRECISE4Q Consortium
FinnGen Consortium
NINDS Stroke Genetics Network (SiGN)
MEGASTROKE Consortium
SIREN Consortium
China Kadoorie Biobank Collaborative Group
VA Million Veteran Program
International Stroke Genetics Consortium (ISGC)
Biobank Japan
CHARGE Consortium

Editors

Advisors

Supervisors

Document Type

Comment

Collections

Open Access logo

License

cc_by

Abstract

Keywords

General, Published Erratum

Citation

PRECISE4Q Consortium, FinnGen Consortium, NINDS Stroke Genetics Network (SiGN), MEGASTROKE Consortium, SIREN Consortium, China Kadoorie Biobank Collaborative Group, VA Million Veteran Program, International Stroke Genetics Consortium (ISGC), Biobank Japan, CHARGE Consortium, GIGASTROKE Consortium, COMPASS Consortium, INVENT Consortium, Dutch Parelsnoer Initiative (PSI) Cerebrovascular Disease Study Group & Estonian Biobank 2022, 'Publisher Correction : Stroke genetics informs drug discovery and risk prediction across ancestries', Nature, vol. 612, no. 7938, pp. E7. https://doi.org/10.1038/s41586-022-05492-5